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Abstract 
Purpose: To investigate the antimicrobial and anti-biofilm activities of essential oil from Mentha 
pulegieum L. (EOMP) on multi-drug resistant (MDR) isolates of A. baumannii, as well as its 
phytochemical composition, antioxidant properties and cytotoxic activity. 
Methods: The phytochemical composition of EOMP was analyzed by gas chromatography, while its 
antimicrobial activities were determined by disc diffusion and broth micro-dilution methods. Minimal 
biofilm inhibition concentration (MBIC) and minimal biofilm eradication concentration (MBEC) tests were 
used for assessment of its anti-biofilm properties. Viability in the biofilm was studied using 2,3-bis (2-
methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay, while colorimetric assay 
was used to assess its cytotoxicity on L929 cells 
Results: D-isomenthone, pulegone, isopulegone, menthol and piperitenone were the major 
components of the plant extract. EOMP produced > 22 mm inhibition zone for the isolates, with 
minimum inhibitory concentration (MIC) and MBIC of 0.6 - 2.5 and 0.6 - 1.25 µL/mL, respectively, while 
MBEC was ≥ 10 µL/msL. EOMP damaged biofilm structures formed by A. baumannii strains at MIC by 
26 – 91 %.  
Conclusion: These results suggest that EOMP contains agents that may be useful in the development 
of new drugs against A. baumannii infections. 
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Acinetobacter baumannii is an aerobic, non-
fermentative, oxidase-negative and non-motile 
Gram-negative bacillus. In recent years, the 
rapidly increasing antimicrobial resistant pattern 
of this bacterium has become a serious medical 
problem associated with hospital-acquired 
infections. A. baumannii causes outbreaks of 
infection and health care–associated infections, 
including bacteremia, bloodstream infections, 
pneumonia, meningitis, urinary tract infection and 
wound infection [1]. 
 
Several factors may be responsible for 
development of virulence and resistance by A. 
baumannii. One of them is the strong biofilm 
activity formed by this bacterium. Biofilm 
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production, which is common in many bacterial 
species, protects pathogens from antimicrobial 
agents and the immune responses of their hosts.  
The frequency and severity A. baumannii 
infections have led to recent and heightened 
interest in understanding and combating the 
menace [2]. 
 
Sessile microorganisms in the biofilms can be 
much more resistant to an agent compared to the 
planktonic forms of the same microorganism. 
Therefore, it is important to understand the 
relationship between the biofilm and the 
resistance encountered in treating bacterial 
infections [3]. 
 
The problem of resistance against the antibiotics, 
which has been increasing substantially, has led 
need to search for new and more effective 
therapeutic agents. Antibiotics were discovered 
from the rich resources of natural products. The 
potential of herbal extracts and some of their 
constituents for overcoming antibiotic-resistant 
bacteria have been extensively reported [4,5]. 
 
M. pulegium L. is a flowery plant from the 
Lamiaceae family which is common worldwide. It 
is known that this plant (also known as 
Pennyroyal) is traditionally used for the treatment 
of many diseases [6]. Although there are 
publications related to the antimicrobial activity of 
the M. pulegium essential oil (EOMP), not much 
is known about its anti-biofilm activity. In this 
study, we aimed at determining the antimicrobial 
and anti-biofilm effects of the EOMP on multi-
drug resistance (MDR) isolates of A. baumannii. 
In addition, the chemical composition of this oil, 





Plant material and extraction of EO 
 
The aerial parts of M. pulegium were collected in 
August of 2014 in Manisa flora located in the 
Aegean Region of Turkey. The samples were 
collected from Gordes county and dried air-dried 
at room temperature. The plant was identified 
and authenticated by a qualified taxonomist in 19 
Mayis University, in Samsun City, in Turkey. At 
the end of the drying process, the leaves and 
flowers were ground before the essential oil was 
extracted by hydro-distillation method using the 
Clevenger apparatus. 
 
Analysis and identification of essential oil 
 
The chemical composition of the essential oil 
was determined according to the method of Aksit 
et al [7]. The GC apparatus used was a Perkin-
Elmer Clarus 500 Series GC system equipped 
with a flame ionization detector (FID) and BPX-5 
apolar capillary column (30 m x 0.25 mm, 0.25 m 
i.d.) connected to a mass spectrometer. 
 
Cultivation of L929 mouse fibroblast cells 
 
Dulbecco’s Modified Eagle Medium (DMEM) 
(Sigma, St.  Louis, MO, USA) was used. L929 
(ATCC cell line, NCTC clone 929), a mouse 
connective tissue fibroblast cell line, was cultured 
in DMEM containing 10 % fetal calf serum 
(Sigma, St. Louis, MO,USA) and 2 mM/mL L-
glutamine. The medium with the cell culture had 
no antibiotic added. Cultivation of the cultures 
was performed in an incubator with 5 % CO2 and 
at 37 °C until confluence was observed in the cell 
monolayer, which occurred after about 7 days. At 
all times, assays were carried out at the 
exponential growth phase of the cells. 
 
Cell proliferation assay 
 
This was carried out according to the procedure 
outlined by Polat et al [8]. In this assay, cell 
viability is assessed through the cleavage of 
tetrazolium salts, which are added to the culture 
medium, and for this, the water soluble 
tetrazolium (WST-1) labeling reagent (Roche, 
Mannheim, Germany) was used. Cellular 
enzymes cleave the tetrazolium salt to formazan, 
the concentration of which is directly proportional 
to the number of metabolically active cells in the 
culture. 
 
Microtiter plates (96-well) were used to seed the 
cells to a concentration of 1 × 105 cells/mL in a 
100 μL final volume for each well. After 24 h, the 
cells were treated with different concentrations of 
EOMP (6.25, 12.5, 25, 50, and 100 % v/v). The 
cells were then incubated for 24 h at 37 oC in a 
humidified atmosphere containing 5 % CO2. 
Thereafter, 10 μL of culture medium (DMEM) in 
each well was added to 10 μL of the WST-1 
labeling reagent. Absorbance was read at 450 
nm against control (untreated cells) in a 
microtiter plate reader (Thermo Scientific 
Microplate Photometer, Multiskan FC, USA). As 
a background control, one well contained culture 
medium and WST-1 labeling reagent (10 μL of 
WST-1 labeling reagent and 10 μL of culture 
medium). The absorbance of this negative 
control was taken 2 h into the tetrazolium 
reaction. Cell viability was as in Eq 1. 
 
Cell viability (%) = (As/Ac)100 ………………(1) 
 
where As and Ac are the absorbance of sample 
and negative control respectively. 
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The method is based on the reduction of 
alcoholic solutions of the stable radical, DPPH by 
electron-donating antioxidants, thereby 
decolorizing it. The amount of DPPH that is left 
after a given time is inversely proportional to the 
radical scavenging activity of the antioxidant [9]. 
Five mL of 0.004 % solution of DPPH in 
methanol was added to 50 microliter of EOMP at 
different concentrations. Absorbance was read 
against a blank at 517 nm after 30 min of 
incubation at room temperature [10]. Eq 2 was 
used to calculate inhibition of DPPH. 
 
Inhibition (%) = {(A0 – A1)/A0}100 …………..(2) 
 
where A0 = control absorbance and A1 = sample 
absorbance. Ascorbic acid, a natural antioxidant 
was used as positive control. All the tests were 




A. baumannii strains used in the study were 
isolated in the Clinical Microbiology Laboratories 
of Cumhuriyet University Hospital between 2013 
and 2014. The bacteria were identified using the 
BD Phoenix (Becton Dickinson, Sparks, MD, 
USA) automated microbiology system and 
antimicrobial susceptibility tests were conducted. 
Resistance and susceptibility of the strains 
against the antimicrobial agents were assessed 
according to the Clinical Laboratory Standards 
Institute (CLSI) [11]. 
 
Evaluation of antimicrobial and anti-biofilm 
activity 
 
Disc diffusion assay 
 
Disc diffusion method was applied, with 100 µL 
of suspension containing 108 CFU/mL of bacteria 
on Mueller Hinton Agar (MHA). After 
impregnation of the disc (6 mm in diameter) with 
20 µL of EOMP (10 µL/disc) at a concentration of 
500 µl/mL, it was placed on the inoculated agar. 
The solvent used for dissolving EOMP was 
utilized to prepare the negative control. The 
inoculated plates were incubated at 37 oC for 24 
h. Zone of inhibition was measured to assess the 
antimicrobial activity against each test organism. 




The broth micro-dilution method which was 
employed to assess the antimicrobial activities of 
the essential oil was done in line with the 
protocol of the CLSI [11]. A micro-well dilution 
method was taken as a basis for determining the 
MIC of EOMP against the bacterial strains. 
 
Twenty four-hour broth cultures were used to 
prepare the inoculums of the microorganisms, 
and suspensions were adjusted to 0.5 McFarland 
standard turbidity. EOMP was dissolved in 
Mueller Hinton Broth (MHB) containing 0.5 % 
(v/v) Tween 20, and serial two-fold dilutions were 
prepared in 96-well plates with MHB at a 
concentrations varying between 0.03 and 2 % 
(v/v). Whereas there was MHB and cells without 
EOMP in the wells of the positive control, wells of 
negative control had only MHB. A BioTek 
microplate reader (Bio Tek Instruments, Inc., 
Winooski, VT, USA) was used to measure the 
absorbance of the plates at 550 nm before and 
after incubation for 24 h at 37 °C. The minimum 
inhibitory concentration (MIC) was detected as 
the lowest concentration of EOMP, and at this 
concentration, the optical density at the 24th h 
incubation of the inoculum remained the same or 
decreased when compared to the reading at the 
beginning. 
 
Ten µL was taken from each well following the 
incubation, spot-inoculated on MHA and 
incubated at 37 °C for 24 h in order to determine 
the minimum bactericidal concentration (MBC) of 
EOMP. The concentration without any growth of 
the subculture was taken as the MBC. 
 
Minimum biofilm inhibitory concentration 
(MBIC) assay 
 
Minimum biofilm inhibitory concentration (MBIC) 
is described as the lowest concentration at which 
the antimicrobial agents prevents the biofilm 
formation [12]. In order to test the anti-biofilm 
activity of EOMP against A. baumannii, the 
microtiter plate assay was used. 
 
The MBIC test was carried out using the method 
of Adukwu et al [13]. An aliquot (100 µL) from an 
overnight culture (diluted with MHB containing 1 
% (w/v) glucose to 108 CFU/ mL) was dispensed 
into each test well of a 96-well plate. Then 100 
µL of different concentrations of EOMP (0.03 – 2 
%) were dispensed into different wells. The 
negative control contained only MHB whereas 
the positive control contained cell cultures alone 
without EOMP. The supernatant of the wells 
were decanted and each well gently rinsed three 
times with 300 µL of sterile distilled water and 
discarded after incubation at 37 °C for 24 h. The 
plates were dried in air for 30 min and stained 
with 0.1 % (w/v) crystal violet at room 
temperature for 30 min, washed 3 times with 
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distilled water and dried. Thereafter the crystal 
violet was solubilized in 95 % ethanol and 
absorbance was read in a microplate reader (Bio 
Tek Instruments, Inc., Winooski, VT, USA) at 550 
nm. MBIC was determined as the EOMP 
concentration at which the absorbance is equal 
to or less than that of the negative control. This 
test was performed in triplicate and the mean (n 
= 3) was taken. 
 
Minimum biofilm eradication concentration 
(MBEC) assay 
 
Minimum biofilm eradication concentration 
(MBEC) is the lowest concentration which can 
damage the structure of emerging biofilm [12]. 
MBEC assay was carried out according to the 
method of Kuzma et al [14]. In essence, 200 μL 
(108 CFU/mL) of each strain was inoculated into 
each well of flat bottom 96-well microtiter plate. 
The wells were incubated at 37 °C for 48 h. After 
biofilm formation, the wells were washed four 
times with sterile distilled water in order to 
remove non-adherent cells. Serial dilutions of 
EOMP (0.03 – 2 %) were added to different wells 
(each EOMP concentration at a volume of 200 
µL). Incubation of the plates was at 37 °C for 24 
h and thereafter the wells were washed with 
distilled water and stained with crystal violet. 
Biofilm without EOMP served as positive control. 
The concentration at which established biofilms 
were removed from the bottom of the treated 
wells was taken as the MBEC. 
 
Evaluation of biofilm eradication 
 
Each A. baumannii strain (200 μL of 108 
CFU/mL) was inoculated into each well of flat 
bottom 96-well microtiter plate and incubated for 
48 h at 37 °C. After biofilm formation, EOMP was 
added to different wells at concentrations 
corresponding to MIC, 1/2MIC, 1/4 MIC and 1/8 
MIC values. The wells were incubated for 24 h, 
washed twice with phosphate buffer saline and 
read at 550 nm. Biofilm eradication was 
calculated as in Eq 3. 
 
Biofilm eradication (%) = {(Ac – As)/Ac}100 …. (2) [15] 
 
where Ac and As are the absorbance of sample 
and control respectively. 
 
Biofilm metabolism assay  
 
Evaluation of the effect of EOMP on the 
metabolic activity of the biofilms formed by the 
bacterial strains was carried out through a 
modification of the tetrazolium salt (XTT) 
reduction test, according to the method of Chaieb 
et al [15]. EOMP at concentrations of 1.25 and 
2.5 μl/mL was applied to the 48 h biofilm 
structures formed in 96-well plates, and after 24 
h incubation, XTT reagent was added to the test 
and control wells. At the end of 5 h incubation 
period, cell viability was determined by reading 




The results are presented as mean ± standard 
deviation (n = 3) and assessed by one-way 
analysis of variance (ANOVA), while Student’s t-
test was applied for comparison between two 





GC and GC-MS data 
 
Table 1 shows results from GC and GC-MS 
analysis of EOMP. 
 
Table 1: Main components of essential oil of aerial 
parts of Mentha pulegium 
 
Rt a Compound (%) b 
4.407 p-Xylene 0.15 
5.689 α-Pinene 0.06 
6.026 Cyclohexanone, 3-methyl- 0.10 
6.661 β-pinene 0.06 
7.096 3-Octanol 0.32 
10.489 3-Octanol, acetate 0.32 
11.163 α-Terpinolen 0.10 
11.299 Isopulegone 9.20 
11.587 D-isomenthone 33.19 
11.899 Menthol 2.98 
13.729 Pulegone 51.32 
14.042 Piperitone 0.83 
16.348 Piperitenone 0.86 
Rta = retention time; (%)b = relative percentage 
obtained from peak area 
 
Cytotoxic potential of M. pulegium EO 
 
Results of cytotoxicity potential of EOMP are 
shown in Figure 1.The toxicity potential of the 50 
% and 100 % EOMP were statistically different 
from that of the control (Figure 1, p < 0.05). 
However there were no significant differences in 
toxicity potential between the control and EOMP 
at concentrations of 6.25, 12.5 and 25 %. 
 
Antioxidant capacity of EOMP 
 
Figure 2 shows the antioxidant capacity of EOMP 
with respect to DPPH scavenging. The EOMP 
scavenged DPPH with an IC50 of 8.82 ± 0.67 
µg/mL, compared to that of ascorbic acid with 
IC50 of 6.97 ± 1.05 µg/mL. 
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Figure 1: In vitro cytotoxic effect of EOMP on L929 
fibroblast cells. *p < 0.05 compared to control 
 
 
Figure 2: DPPH radical scavenging activity of EOMP. 
IC50 is the concentration of EOMP that scavenged 50 
% of DPPH radical. All data are presented as the 
mean ± SD for three replicates 
 
 
Antimicrobial and antibiofilm activities 
 
The inhibition zones due to antimicrobial effect of 
EOMP on the 22 strains of A. pulegium tested 
are shown in Table 2. EOMP formed more than 
22 mm inhibition zones in all the strains. The MIC 
values of EOMP were 2.5 µl/mL in 15 strains, 
1.25 µl/mL in 2 strains, and 0.6 µl/mL in 5 strains. 
Values of MBC were 5 µl/mL in 18 strains and 
2.5 µl/mL in 4 strains. MBIC value was 0.6 µl/mL 
in 2 strains, and 1.25 µl/mL in the other strains. 
MBEC value was ≥ 10 µl/mL in all the strains. 
 
Reduction in biofilm formation 
 
MIC, 1/2MIC, 1/4 MIC and 1/8 MIC values of the 
M. pulegium EO were applied onto the bacterial 
biofilm formations that emerged after the 48h 
incubation. It was observed that the effect of the 
EO on the biofilm structure decreased as the 
concentration reduced. It was seen that the M. 
pulegium EO damaged the biofilm structure at 
the MIC value by 26-91 % (Table 3). 
 
Inhibition of metabolic activity  
 
EOMP decreased the metabolic activity of the 48 
h biofilm structures formed by MDR A. baumannii 
strains in a concentration-dependent manner 
(Figure 3). 
Table 2: Antimicrobial and anti-biofilm activities of EOMP against MDR Acinetobacter baumannii 
 








1 24.6±2.0 2.5 5 1.25 ≥10 
2 26.3±3.0 2.5 5 1.25 ≥10 
3 27.6±1.1 2.5 5 1.25 ≥10 
4 23.3±1.1 2.5 5 1.25 ≥10 
5 22.0±1.5 2.5 5 1.25 ≥10 
6 22.0±1.5 2.5 5 1.25 ≥10 
7 22.6±0.8 2.5 5 1.25 ≥10 
8 22.6±0.8 2.5 5 1.25 ≥10 
9 30.6±3.7 0.6 2.5 1.25 ≥10 
10 31.1±3.0 0.6 2.5 0.6 ≥10 
11 22.6±0.8 2.5 5 1.25 ≥10 
12 24.3±1.1 2.5 5 1.25 ≥10 
13 32.6±0.5 0.6 2.5 0.6 ≥10 
14 23.0±3.0 2.5 5 1.25 ≥10 
15 23.6±1.5 2.5 5 1.25 ≥10 
16 27±1.7 1.25 5 1.25 ≥10 
17 31.6±3.5 0.6 2.5 1.25 ≥10 
18 23.3±1.1 0.6 5 1.25 ≥10 
19 25.3±2.5 2.5 5 1.25 ≥10 
20 25.6±2.0 2.5 5 1.25 ≥10 
21 26.3±1.5 2.5 5 1.25 ≥10 
22 27.6±1.5 1.25 5 1.25 ≥10 
MIC = minimum inhibitory concentration, MBC = minimum bactericidal concentration, MBIC = minimum biofilm inhibitory 
concentration, MBEC = minimum biofilm eradication concentration; avalues are reported as mean  ±  SD (mm, n = 3) 
Tutar et al 
Trop J Pharm Res, May 2016; 15(5): 1044  
 
Table 3:  Reduction in biofilm formation 
 
Strain MIC                                1/2 MIC                         1/4 MIC                        1/8 MIC 
1 85,6±1.5 56.3±3.05 25.0±1.7 8.3±1.5 
2 85.0±4.3 84.3±4.7 23.3±2.5 2.3±1.1 
3 86.0±7.0 89.3±1.1 16.3±3.5 5.3±2.5 
4 86.6±2.0 33.3±2.5 34.0±2.0 12.6±0.5 
5 80.3±0.5 75.6±3.0 25.0±3.6 13.6±2.0 
6 87.6±1.5 82.6±4.5 18.3±4.0 2.3±1.5 
7 89.0±1.0 84.3±5.6 27.6±3.5 4.6±3.7 
8 78.0±1.7 77.0±4.0 13.6±1.1 2.6±0.5 
9 26.3±2.0 5.0±1.0 NT NT 
10 41.0±2.6 2.33±0.5 NT NT 
11 91.0±2.6 90.3±2.5 28.6±0.5 24.0±2.0 
12 87.0±2.0 35.0±2.6 22.6±1.5 9.6±3.5 
13 36.0±2.6 8.3±1.5 NT NT 
14 84.6±3.2 78.0±8.1 25.0±5.2 25.3±2.5 
15 82.0±4.0 73.0±6.2 11.3±1.5 10.3±3.2 
16 56.3±6.1 26.3±7.5 24.0±3.6 NT 
17 57.3±2.8 46.6±4.04 NT NT 
18 34.3±4.1 25.6±3.05 NT NT 
19 83.6±5.1 76.6±6.5 32.6±1.5 3.0±1.7 
20 84.3±6.02 79.6±4.7 47.6±3.5 38.0±3.0 
21 86.3 ±0.5 73.0±2.0 46.6±5.5 26.6±3.2 
22 83.3±3.5 69.0±2.6 33.3±2.8 NT 
Data are reported as mean ± SD (n = 3); NT =not tested 
 
 
Figure 3: Changes in metabolic activity following 48 h exposure of biofilms of MDR A. baumannii strains to   
EOMP, as determined by XTT assay (control = biofilms not exposed to EOMP). All data are presented as mean ± 




Natural products are sources of chemical 
compounds that have been used as alternative 
medicines to conventional therapy. Currently, 
researchers are focusing on the pharmacological 
and therapeutic activities of plant products. 
 
This study demonstrates that the essential oil of 
Mentha pulegium exhibits anti-biofilm and 
antimicrobial activities multi-drug resistant strains 
of Acinetobacter baumannii. In addition, the 
study demonstrated the antioxidant properties, 
cytotoxic activity and chemical composition of M. 
pulegium EO. 
 
M. pulegium essential oil has strong antimicrobial 
activity on MDR A. baumannii isolates. It was 
observed that the MIC which has effect on 
planctonic forms are not adequately effective on 
the biofilm structure. In the XTT test, MIC was 
not completely effective on the sessile forms in 
the biofilm, so that viability continued. Therefore, 
we concluded that it will be appropriate to 
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investigate the anti-biofilm activity of the 
essential oil, and regulate the treatments 
accordingly. All the A. baumannii strains used in 
this study were found resistant to the tested 
antibiotics (amikacin, cefepime, ceftazidime, 
gentamycin, imipenem, meropenem). The 
cytotoxic potential of 50 % EOMP was 
significantly different from that of control.  The 
MIC, MBIC and MBEC values of EOMP (≥0.6-2.5 
µl/mL, 0.6-2.5 µl/mL and 10 µl/mL, respectively) 
were quite below the cytotoxic value, blocked 
microbial biofilm formation even at low 
concentrations, and eradicated emerging biofilm 
structures in a concentration-dependent manner 
even at concentrations below MIC. These results 
indicate that EOMP has effective antimicrobial 
and anti-biofilm activities against A. baumannii. 
 
DPPH radical scavenging activity assay was 
used to evaluate the possible antioxidant 
properties of the M. pulegium essential oil. The 
results obtained confirm previous reports on the 
importance of essential oils as natural 
antioxidants [23-25]. A previous study reported 
that extracts from some Mentha species (M. 
longifolia (L.) Huds., M. piperita L., M. pulegium 
L., M. rotundifolia (L.) Huds., and M. spicata L.) 
have antioxidant and free radical -scavenging 
properties [26]. The antioxidant properties of 
Mentha extracts may be due to their 
phytochemical compositions. Previous studies 
reported that M. pulegium has strong antioxidant 
components [27]. According to result of the 
present study, M. pulegium essential oil can be 
considered as a strong antioxidant and a strong 
antimicrobial agent.  
 
The major components of EOMP were pulegone 
(51.32 %), D-isomenthone (33.19 %), 
isopulegone (9.20 %), menthol (2.98 %) and 
piperitenone (0.86 %). This is in agreement with 
components reported from other studies on M. 
pulegium [28,29]. In 2005, Agnihotri et al 
reported pulegone (65.9-83.1 %) and menthone 
(8.3-8.7 %) as the major components of the oil of 
M. pulegium collected from different locations in 
India. Pulegone, piperitenone and isomenthone 
were reported as the main compounds of the oil 
of M. pulegium from Bulgaria [30,31]. It was also 
stated in these studies that the essential oil had 
antimicrobial activity against various 
microorganisms. The major components of the 
oil were similar, but may vary according to 
geographical regions where the plant was 
harvested, or due to seasonal conditions 
[23,28,29,32]. Some previous studies reported 
that pulegone, isomenthone, piperitenone 
exhibited high antibacterial and antifungal 
activities [21,33,34]. Thus the antimicrobial and 
anti-biofilm properties of EOMP could be 




The findings of this study show that M. pulegium 
essential oil has strong antimicrobial and anti-
biofilm activity against MDR A. baumannii 
isolates. Thus, it is a potential agent for the 
treatment of MDR A. baumannii infections. In 
addition, the results provide evidence that the 
essential oil of M. pulegium may be a useful 
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